Skip to main content
Premium Trial:

Request an Annual Quote

AlphaGene, Wayne State Partner to Study Brain Tumors

NEW YORK, Sept 11 – AlphaGene of Woburn, Mass., said Tuesday it has signed an agreement with Wayne State University to study malignant brain tumor cell types using gene expression technology.

Under the terms of the deal, AlphaGene will contribute its expertise in functional genomics, while Wayne State University will provide its research capabilities. Financial terms of the deal were not disclosed.

AlphaGene and Wayne State will also look to correlate gene expression patterns with treatment regimens and aim to develop new diagnostic and prognostic methods.

"We believe that by combining our technologies and expertise, we will gain a better insight into the genetic causes of the disease, and in so doing, we will identify new validated drug targets and markers for these difficult to treat brain tumors,” Donald McCarren, president and CEO of AlphaGene, said in a statement.

Wayne State University is currently developing a bank of brain tumors and normal blood specimens from consenting patients.

AlphaGene is a biotechnology company conducting research relating to neuro-degenerative diseases and cancer.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.